Some patients on Tirzepatide have reported losing up to 20% of their body weight
In contrast, dietary d-carnitine intake reduced the acyl-carnitine concentration in the body and induced lipid accumulation in the liver, which was accompanied by lipotoxicity
So we really wanted to tackle: if obesity is a disease and we want to treat it as such, like we have other chronic diseases, tell me what the signs and symptoms are of that disease
Abstract Currently, there is no disease-modifying treatment available for Alzheimers and Parkinsons disease (AD and PD) and that includes the highly controversial approval of the A-targeting antibody aducanumab for the treatment of AD
If amycretin succeeds, it could make cagrilintide as a standalone product less relevant, though the amylin mechanism it pioneered would live on in the new molecule
Which works best for someone with fatty liver disease